A Constitutively Active NFATc1 Mutant Induces a Transformed Phenotype in 3T3-L1 Fibroblasts*

The calcineurin/nuclear factor of activated T cells (NFAT) signaling pathway is best known for its role in T lymphocyte activation. However, it has become increasingly apparent that this signaling pathway is also involved in the regulation of cell growth and development in a wide variety of different tissues and cell types. Here we have investigated the effects of sustained NFATc1 signaling on the growth and differentiation of the murine 3T3-L1 preadipocyte cell line. Remarkably, we find that expression of a constitutively active NFATc1 mutant (caNFATc1) in these immortalized cells inhibits their differentiation into mature adipocytes and causes them to adopt a transformed cell phenotype, including loss of contact-mediated growth inhibition, reduced serum growth requirements, protection from growth factor withdrawal-induced apoptosis, and formation of colonies in semisolid media. Furthermore, we find that caNFATc1-expressing cells acquire growth factor autonomy and are able to proliferate even in the complete absence of serum. We provide evidence that this growth factor independence is caused by the NFATc1-dependent production of a soluble heat-labile autocrine factor that is capable of promoting the growth and survival of wild type 3T3-L1 cells as well as potently inhibiting their differentiation into mature adipocytes. Finally, we demonstrate that cells expressing caNFATc1 form tumors in nude mice. Taken together, these results indicate that deregulated NFATc1 activity is able to induce the immortalized 3T3-L1 preadipocyte cell line to acquire the well established hallmarks of cellular transformation and thereby provide direct evidence for the oncogenic potential of the NFATc1 transcription factor.

[1]  J. Neal,et al.  Calcineurin Mediates the Calcium-dependent Inhibition of Adipocyte Differentiation in 3T3-L1 Cells* , 2002, The Journal of Biological Chemistry.

[2]  S. O’Rahilly,et al.  Microarray Analysis of Insulin and Insulin-like Growth Factor-1 (IGF-1) Receptor Signaling Reveals the Selective Up-regulation of the Mitogen Heparin-binding EGF-like Growth Factor by IGF-1* , 2002, The Journal of Biological Chemistry.

[3]  J. Decaprio,et al.  NFATc2-mediated repression of cyclin-dependent kinase 4 expression. , 2002, Molecular cell.

[4]  Christopher C. W. Hughes,et al.  Endothelial Cells Stimulate T Cell NFAT Nuclear Translocation in the Presence of Cyclosporin A: Involvement of the wnt/Glycogen Synthase Kinase-3β Pathway1 , 2002, The Journal of Immunology.

[5]  Leslie M. Shaw,et al.  The role of NFAT transcription factors in integrin-mediated carcinoma invasion , 2002, Nature Cell Biology.

[6]  Katsuhiko Mikoshiba,et al.  The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos , 2002, Nature.

[7]  N. Clipstone,et al.  Sustained NFAT Signaling Promotes a Th1-Like Pattern of Gene Expression in Primary Murine CD4+ T Cells1 , 2002, The Journal of Immunology.

[8]  G. Crabtree,et al.  NFAT Signaling Choreographing the Social Lives of Cells , 2002, Cell.

[9]  M. Bittner,et al.  Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. , 2002, Cancer cell.

[10]  Valerie Horsley,et al.  NFAT: ubiquitous regulator of cell differentiation and adaptation. , 2002, The Journal of cell biology.

[11]  H. Abboud,et al.  Insulin-like Growth Factor-I Induces Renal Cell Hypertrophy via a Calcineurin-dependent Mechanism* , 2001, The Journal of Biological Chemistry.

[12]  Feng Chen,et al.  Signals Transduced by Ca2+/Calcineurin and NFATc3/c4 Pattern the Developing Vasculature , 2001, Cell.

[13]  J. Redondo,et al.  Selective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a , 2001, The Journal of experimental medicine.

[14]  J. Neal,et al.  Glycogen Synthase Kinase-3 Inhibits the DNA Binding Activity of NFATc* , 2001, The Journal of Biological Chemistry.

[15]  F. Berberich-Siebelt,et al.  The role of NF-AT transcription factors in T cell activation and differentiation. , 2000, Biochimica et biophysica acta.

[16]  T. Rohan,et al.  Role of the insulin-like growth factor family in cancer development and progression. , 2000, Journal of the National Cancer Institute.

[17]  P. Polakis Wnt signaling and cancer. , 2000, Genes & development.

[18]  S. Feske,et al.  The Duration of Nuclear Residence of NFAT Determines the Pattern of Cytokine Expression in Human SCID T Cells1 , 2000, The Journal of Immunology.

[19]  N. Clipstone,et al.  Identification of Amino Acid Residues and Protein Kinases Involved in the Regulation of NFATc Subcellular Localization* , 2000, The Journal of Biological Chemistry.

[20]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[21]  M. Glimcher,et al.  The Nuclear Factor of Activated T Cells (Nfat) Transcription Factor Nfatp (Nfatc2) Is a Repressor of Chondrogenesis , 2000, The Journal of experimental medicine.

[22]  R. Baserga The IGF-I receptor in cancer research. , 1999, Experimental cell research.

[23]  A. Musarò,et al.  IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1 , 1999, Nature.

[24]  Richard P. Harvey,et al.  Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway , 1999, Nature.

[25]  R. Lyle,et al.  Molecular regulation of adipocyte differentiation. , 1999, Seminars in cell & developmental biology.

[26]  A. Buonanno,et al.  Fiber-Type-Specific Transcription of the Troponin I Slow Gene Is Regulated by Multiple Elements , 1999, Molecular and Cellular Biology.

[27]  J. W. Rooney,et al.  A potential role for the nuclear factor of activated T cells family of transcriptional regulatory proteins in adipogenesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Serfling,et al.  The Interleukin 2 Receptor α Chain/CD25 Promoter Is a Target for Nuclear Factor of Activated T Cells , 1998, The Journal of experimental medicine.

[29]  W. Zhu,et al.  A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. , 1998, Genes & development.

[30]  Thomas J. Murphy,et al.  The Cyclosporin A-sensitive Nuclear Factor of Activated T Cells (NFAT) Proteins Are Expressed in Vascular Smooth Muscle Cells , 1998, The Journal of Biological Chemistry.

[31]  R. DuBois,et al.  Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.

[32]  F. Shibasaki,et al.  Intramolecular Masking of Nuclear Import Signal on NF-AT4 by Casein Kinase I and MEKK1 , 1998, Cell.

[33]  Keli Xu,et al.  Calcium oscillations increase the efficiency and specificity of gene expression , 1998, Nature.

[34]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[35]  Tak W. Mak,et al.  Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum , 1998, Nature.

[36]  Michael J. Grusby,et al.  The transcription factor NF-ATc is essential for cardiac valve formation , 1998, Nature.

[37]  M Dickens,et al.  Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. , 1997, Science.

[38]  Christopher C. Goodnow,et al.  Differential activation of transcription factors induced by Ca2+ response amplitude and duration , 1997, Nature.

[39]  Christoph W. Turck,et al.  Nuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3 , 1997, Science.

[40]  C. Sherr Cancer Cell Cycles , 1996, Science.

[41]  G. Crabtree,et al.  Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression , 1996, Nature.

[42]  E. Price,et al.  Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4 , 1996, Nature.

[43]  Anjana Rao,et al.  An Enhanced Immune Response in Mice Lacking the Transcription Factor NFAT1 , 1996, Science.

[44]  L. Glimcher,et al.  Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. , 1996, Immunity.

[45]  G. Vassaux,et al.  Proliferation and differentiation of rat adipose precursor cells in chemically defined medium: Differential action of anti‐adipogenic agents , 1994, Journal of cellular physiology.

[46]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[47]  M. Brann,et al.  Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G. Crabtree,et al.  Identification of a putative regulator of early T cell activation genes. , 1988, Science.

[49]  G. Serrero EGF inhibits the differentiation of adipocyte precursors in primary cultures. , 1987, Biochemical and biophysical research communications.

[50]  T. Shows,et al.  Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. , 1986, Cancer research.

[51]  D. Cantrell,et al.  The interleukin-2 T-cell system: a new cell growth model. , 1984, Science.

[52]  P. Briand,et al.  The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. , 1975, Cancer research.

[53]  B. Spiegelman,et al.  Molecular regulation of adipogenesis. , 2000, Annual review of cell and developmental biology.

[54]  F. Alt,et al.  Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. , 1998, Immunity.

[55]  G. Crabtree,et al.  The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. , 1998, Immunity.

[56]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[57]  Anita B. Roberts,et al.  Autocrine growth factors and cancer , 1985, Nature.